# To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

> **NCT00141414** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 82 (—)

## Conditions studied

- Epilepsy, Partial

## Interventions

- **DRUG:** Pregabalin

## Key facts

- **NCT ID:** NCT00141414
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-11
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** 82 (—)
- **Last updated:** 2007-01-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00141414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00141414, "To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00141414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*